Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:429-435
doi: 10.1161/hc2901.093198
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, X.-G.
Right arrow Articles by Wasserman, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, X.-G.
Right arrow Articles by Wasserman, K.
Related Collections
Right arrow Pulmonary circulation and disease
Right arrow Exercise testing
Right arrow Pulmonary biology and circulation

(Circulation. 2001;104:429.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension

Xing-Guo Sun, MD; James E. Hansen, MD; Ronald J. Oudiz, MD; Karlman Wasserman, MD, PhD

From the Department of Medicine, Harbor-UCLA Medical Center, Torrance, Calif.

Correspondence to Karlman Wasserman, MD, PhD, Department of Medicine, Harbor-UCLA Medical Center, 1000 W Carson St, Box 405, Torrance, CA 90509-2910. E-mail kwasserm{at}ucla.edu

Background— Patients with primary pulmonary hypertension (PPH) have a pulmonary vasculopathy that leads to exercise intolerance due to dyspnea and fatigue. To better understand the basis of the exercise limitation in patients with PPH, cardiopulmonary exercise testing (CPET) with gas exchange measurements, New York Heart Association (NYHA) symptom class, and resting pulmonary hemodynamics were studied.

Methods and Results— We retrospectively evaluated 53 PPH patients who had right heart catheterization and cycle ergometer CPET studies to maximum tolerance as part of their clinical workups. No adverse events occurred during CPET. Reductions in peak O2 uptake ({image}O2), anaerobic threshold, peak O2 pulse, rate of increase in {image}O2, and ventilatory efficiency were consistently found. NYHA class correlated well with the above parameters of aerobic function and ventilatory efficiency but less well with resting pulmonary hemodynamics.

Conclusions— Patients with PPH can safely undergo noninvasive cycle ergometer CPET to their maximal tolerance. The CPET abnormalities were consistent and characteristic and correlated well with NYHA class.


Key Words: oxygen • hypertension, pulmonary • ventilation • exercise • hemodynamics




This article has been cited by other articles:


Home page
Eur Respir JHome page
S. Provencher, P. Herve, O. Sitbon, M. Humbert, G. Simonneau, and D. Chemla
Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension
Eur. Respir. J., August 1, 2008; 32(2): 393 - 398.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Heart, March 1, 2008; 94(Suppl_1): i1 - i41.
[Full Text] [PDF]


Home page
ThoraxHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. Naeije and S. Huez
Right ventricular function in pulmonary hypertension: physiological concepts
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H5 - H9.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
I. M. Lang
Management of acute and chronic RV dysfunction
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H61 - H67.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. M. Hoeper, M. W. Pletz, H. Golpon, and T. Welte
Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension
Eur. Respir. J., May 1, 2007; 29(5): 944 - 950.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. L. Alkotob, P. Soltani, M. A. Sheatt, M. C. Katsetos, N. Rothfield, W. D. Hager, R. J. Foley, and D. I. Silverman
Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma.
Chest, July 1, 2006; 130(1): 176 - 181.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Dimopoulos, D. O. Okonko, G.-P. Diller, C. S. Broberg, T. V. Salukhe, S. V. Babu-Narayan, W. Li, A. Uebing, S. Bayne, R. Wensel, et al.
Abnormal Ventilatory Response to Exercise in Adults With Congenital Heart Disease Relates to Cyanosis and Predicts Survival
Circulation, June 20, 2006; 113(24): 2796 - 2802.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Holverda, C. T.-J. Gan, J. T. Marcus, P. E. Postmus, A. Boonstra, and A. Vonk-Noordegraaf
Impaired Stroke Volume Response to Exercise in Pulmonary Arterial Hypertension
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1732 - 1733.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. Provencher, D. Chemla, P. Herve, O. Sitbon, M. Humbert, and G. Simonneau
Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension
Eur. Respir. J., January 1, 2006; 27(1): 114 - 120.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Deboeck, G. Niset, J-L. Vachiery, J-J. Moraine, and R. Naeije
Physiological response to the six-minute walk test in pulmonary arterial hypertension
Eur. Respir. J., October 1, 2005; 26(4): 667 - 672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Chaouat, A.-S. Bugnet, N. Kadaoui, R. Schott, I. Enache, A. Ducolone, M. Ehrhart, R. Kessler, and E. Weitzenblum
Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 189 - 194.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Y. Yasunobu, R. J. Oudiz, X.-G. Sun, J. E. Hansen, and K. Wasserman
End-tidal PCO2 Abnormality and Exercise Limitation in Patients With Primary Pulmonary Hypertension
Chest, May 1, 2005; 127(5): 1637 - 1646.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. Naeije
Breathing more with weaker respiratory muscles in pulmonary arterial hypertension
Eur. Respir. J., January 1, 2005; 25(1): 6 - 8.
[Full Text] [PDF]


Home page
Eur Respir JHome page
F. J. Meyer, D. Lossnitzer, A. V. Kristen, A. M. Schoene, W. Kubler, H. A. Katus, and M. M. Borst
Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension
Eur. Respir. J., January 1, 2005; 25(1): 125 - 130.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. E. Hansen, X.-G. Sun, Y. Yasunobu, R. P. Garafano, G. Gates, R. J. Barst, and K. Wasserman
Reproducibility of Cardiopulmonary Exercise Measurements in Patients With Pulmonary Arterial Hypertension
Chest, September 1, 2004; 126(3): 816 - 824.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. H. Leuchte, C. Neurohr, R. Baumgartner, M. Holzapfel, W. Giehrl, M. Vogeser, and J. Behr
Brain Natriuretic Peptide and Exercise Capacity in Lung Fibrosis and Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 360 - 365.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. J. Rubin and R. Naeije
Sildenafil for Enhanced Performance at High Altitude?
Ann Intern Med, August 3, 2004; 141(3): 233 - 235.
[Full Text] [PDF]


Home page
ChestHome page
M. McGoon, D. Gutterman, V. Steen, R. Barst, D. C. McCrory, T. A. Fortin, and J. E. Loyd
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines
Chest, July 1, 2004; 126(1_suppl): 14S - 34S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Barst, M. McGoon, A. Torbicki, O. Sitbon, M. J. Krowka, H. Olschewski, and S. Gaine
Diagnosis and differential assessment of pulmonary arterial hypertension
J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 40S - 47S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Hoeper, R. J. Oudiz, A. Peacock, V. F. Tapson, S. G. Haworth, A. E. Frost, and A. Torbicki
End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives
J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 48S - 55S.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Peacock, R. Naeije, N. Galie, and J.T. Reeves
End points in pulmonary arterial hypertension: the way forward
Eur. Respir. J., June 1, 2004; 23(6): 947 - 953.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Deboeck, G. Niset, M. Lamotte, J-L. Vachiery, and R. Naeije
Exercise testing in pulmonary arterial hypertension and in chronic heart failure
Eur. Respir. J., May 1, 2004; 23(5): 747 - 751.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. H. Leuchte, M. Holzapfel, R. A. Baumgartner, I. Ding, C. Neurohr, M. Vogeser, T. Kolbe, M. Schwaiblmair, and J. Behr
Clinical significance of brain natriuretic peptide in primary pulmonary hypertension
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 764 - 770.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. W Mikhail, S. K Prasad, W. Li, P. Rogers, A. H Chester, S. Bayne, D. Stephens, M. Khan, J.S.R Gibbs, T. W Evans, et al.
Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects
Eur. Heart J., March 1, 2004; 25(5): 431 - 436.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Glaser, C. F. Opitz, U. Bauer, R. Wensel, R. Ewert, P. E. Lange, and F. X. Kleber
Assessment of Symptoms and Exercise Capacity in Cyanotic Patients With Congenital Heart Disease
Chest, February 1, 2004; 125(2): 368 - 376.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M.M. Hoeper, N. Taha, A. Bekjarova, R. Gatzke, and E. Spiekerkoetter
Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids
Eur. Respir. J., August 1, 2003; 22(2): 330 - 334.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X.-G. Sun, J. E. Hansen, R. J. Oudiz, and K. Wasserman
Pulmonary function in primary pulmonary hypertension
J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1028 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
ATS/ACCP Statement on Cardiopulmonary Exercise Testing
Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
X.-G. Sun, J. E. Hansen, N. Garatachea, T. W. Storer, and K. Wasserman
Ventilatory Efficiency during Exercise in Healthy Subjects
Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1443 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. Chemla, V. Castelain, P. Herve, Y. Lecarpentier, and S. Brimioulle
Haemodynamic evaluation of pulmonary hypertension
Eur. Respir. J., November 1, 2002; 20(5): 1314 - 1331.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N Nagaya, Y Shimizu, T Satoh, H Oya, M Uematsu, S Kyotani, F Sakamaki, N Sato, N Nakanishi, and K Miyatake
Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension
Heart, April 1, 2002; 87(4): 340 - 345.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X.-G. Sun, J. E. Hansen, R. J. Oudiz, and K. Wasserman
Gas Exchange Detection of Exercise-Induced Right-to-Left Shunt in Patients With Primary Pulmonary Hypertension
Circulation, January 1, 2002; 105(1): 54 - 60.
[Abstract] [Full Text] [PDF]